Hans-Peter Gerber, CHIEF SCIENTIFIC OFFICER at SUTRO BIOPHARMA, INC. (STRO), bought 17,000 shares at $0.80 ($14K) on 2025-10-15, disclosed to the SEC on 2025-10-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.